Biosimilar Trastuzumab Injection from Japan
Biosimilar version of trastuzumab monoclonal antibody for HER2 cancers. HTS 3002.15.00.11 as interchangeable immunological product.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Distinguish from originator with biosimilar docs